
Portal Shedrx
Portal Shedrx is an online-only telehealth brand that prescribes and ships GLP-1 receptor agonist weight-loss medications—primarily compounded semaglutide and tirzepatide—directly to patients. After a $49 virtual consultation, qualifying customers receive monthly subcutaneous injection kits priced at $199–$399, placing the offer in the mid-range between discount compounding pharmacies and premium brick-and-mortar clinics. All prescriptions are filled through partnered U.S. compounding pharmacies and delivered in temperature-controlled packaging.
The company’s core edge is a fully digital, subscription-based model that bundles provider consults, dosage titration support, and medication into one recurring shipment. Each patient is assigned a clinician who monitors progress via a HIPAA-compliant portal, and refills are automatically calibrated to the individual’s titration schedule. This integrated “prescription-to-doorstep” system lets users avoid retail pharmacies and in-office visits while still accessing the same active ingredients found in higher-priced name-brand injectables.
Typical buyers are 25-55-year-old U.S. residents with a BMI ≥27 who want clinically significant weight loss without insurance hurdles or time-consuming clinic appointments. The brand speaks to value-driven, tech-savvy consumers who prioritize convenience, privacy, and transparent cash pricing over traditional healthcare rituals.
Portal Shedrx competes with telehealth platforms, med-spa chains, and cash-pay compounding pharmacies that market similar GLP-1 programs. It differentiates by combining proprietary clinician oversight, fixed monthly pricing that includes medication, and an interface that automates dose adjustments—delivering a more cohesive, app-managed experience than piecemeal prescription or injection services.
Weight loss that actually fits your life, delivered to your door
Visit site
Trimrx
Trimrx is an online-only direct-to-consumer brand that sells compounded GLP-1 weight-loss injections—primarily semaglutide and tirzepatide—along with telehealth consultations, starter supply kits, and monthly refill plans. All medications are prescribed and fulfilled through the company’s U.S.-partnered pharmacies; no insurance is required. Pricing sits in the mid-range tier: starter programs open at roughly $299 and monthly refills run $399–$499, placing the brand below most in-clinic peptide clinics but above budget pill-based alternatives.
The company’s core promise is “prescription GLP-1 in 48 hours”: patients complete an asynchronous intake, a state-licensed clinician reviews within one business day, and medication ships overnight from an affiliated pharmacy. Doses are customized to the nearest 0.1 mg, vials arrive in temperature-controlled packaging with pre-loaded syringes, and unlimited dosage adjustments are included. Trimrx markets itself as the fastest, most transparent tele-GLP-1 option, publishing real-time pharmacy inventory and batch-level Certificates of Analysis online.
Trimrx targets busy professionals aged 25-55 who want clinically proven weight-loss injectables without clinic visits, insurance hurdles, or brand-name mark-ups. Customers value speed, privacy, and data—many track body-composition metrics and share progress in the brand’s private Slack community. The aesthetic is clean, medical-minimalist, appealing to consumers who already subscribe to DTC services for hair, skin, or hormone care.
Competitors include other telehealth platforms offering compounded semaglutide, cash-pay medical spas, and traditional pharmacies. Trimrx differentiates through faster fulfillment (48-hour average), flat monthly pricing that covers all clinician touchpoints, and public lot-level testing—practices not universally offered by rival tele-GPL-1 sites.
GLP-1 in 48 hours, transparent dosing, no clinic visits required
Visit site
bmiMD
bmiMD sells physician-formulated GLP-1 weight-management protocols, compounded tirzepatide and semaglutide injections, plus supporting supplements (B-complex, magnesium, probiotics). All medication is shipped frozen from U.S. pharmacies; plans start around $299 for a 4-week starter dose and rise to $599 for the highest maintenance strength. The brand is online-only: patients complete a telehealth intake, upload labs, and receive doorstep delivery if prescribed.
The company differentiates by bundling unlimited provider messaging, nutrition coaching, and dose-adjustment visits into the drug price—no separate app fees. Medication is compounded in small batches to order, letting bmiMD offer two vial strengths not found in standard starter pens and ship in temperature-stable cold packs that keep potency for 72 h. A 90-day outcomes guarantee—free month if weight loss is under 5 %—is heavily promoted on TikTok and Instagram.
Core buyers are 28-55-year-old professionals (70 % female) with ≥25 BMI who want clinical-grade loss without sitting in a clinic. They value transparent pricing, on-demand texting with an NP, and the discretion of home delivery over branded injectables advertised on TV. Many report choosing bmiMD after insurance denied name-brand GLP-1 coverage.
bmiMD competes with telehealth platforms, med-spas, and compounding pharmacies that market similar peptides. It undercuts cash-pay retail prices by 20-30 % while wrapping physician oversight, coaching, and cold-chain logistics into one subscription, positioning itself as the fastest route from online consult to doorstep medication without sacrificing medical supervision.
Clinical-grade weight loss delivered frozen to your door, no clinic required
Visit site
Ivim Health
Ivim Health is a telemedicine platform that prescribes and ships GLP-1 receptor agonist weight-loss medications (semaglutide and tirzepatide) and complementary metabolic-support supplements. All care is delivered online through a $129–$149 monthly membership that includes provider consults, unlimited messaging, and free 2-day pharmacy shipping; the drugs themselves are billed separately and priced at or below typical retail pharmacy levels. The company operates only through its website—no physical clinics—and accepts HSA/FSA cards but not insurance for the membership fee.
The brand’s core promise is “MD-led weight loss in 24 hr”: patients complete an intake, receive same-day provider review, and—if medically eligible—have medication dispatched from Ivim’s partnered sterile compounding pharmacies. Ivim formulates its own flavored sublingual and injection kits, advertises transparent batch testing, and provides a mobile dashboard that syncs with smart scales to track BMI, visceral fat, and glucose trends. Its most visible offering is the “QuickStart GLP-1 Trio,” a four-week introductory pack that bundles titrated semaglutide, B12 shots, and craving-control lozenges.
Typical customers are U.S. adults 25-55 with BMI ≥27 who want clinical-grade obesity treatment without long waitlists or insurance hurdles; many are busy professionals, post-partum women, and remote workers already comfortable with subscription services. They value speed, privacy, and data-driven feedback, and they prefer a cash-pay model that keeps treatment off employer health records.
Ivim competes with national telehealth weight-loss programs, cash-pay clinic chains, and compound pharmacies that market directly on social media. It differentiates by integrating prescription issuance, in-house drug manufacturing, and biometric tracking inside one vertically controlled platform, promising faster fulfillment (24 hr vs. 3-7 days) and tighter clinical oversight (MDs, not nurse pools) than most low-cost rivals while staying cheaper than concierge metabolic clinics.
Weight loss that actually keeps up with your life
Visit site
Orderlymeds
Orderlymeds is an online-only telehealth pharmacy that focuses on GLP-1 receptor agonist weight-loss injections—primarily compounded semaglutide and tirzepatide—sold in 4-, 8-, and 12-week subscription kits. Prices sit in the mid-range bracket: about $299-$549 per month, including medication, tele-consult, supplies, and free 2-day shipping; no insurance is required. The site also stocks supporting items such as alcohol swabs, sharps containers, and vitamin B12 lipo-combo add-ons, all bundled into the same checkout flow.
The brand’s core promise is “doctor-guided, pharmacy-delivered” in one seamless loop: patients complete an intake form, are reviewed by a U.S.-licensed clinician within 24 h, and receive medication from an affiliated PCAB-certified compounding pharmacy. All vials are compounded on-demand in the United States, labeled with batch and beyond-use dates, and shipped cold-chain in reusable gel-pack mailers. Orderlymeds markets transparency—posting third-party lab results for potency and sterility on each product page—and offers a 30-day refund if treatment is discontinued for medical reasons.
Typical buyers are 25-55-year-old professionals who want clinically proven weight-loss medication without brick-and-mortar clinic visits or insurance hurdles; many report BMI just above insurance-cutoff thresholds or prefer privacy. The brand speaks to value-driven pragmatists who track macros, use wearables, and favor subscription convenience over luxury aesthetics.
Orderlymeds competes with national telehealth platforms, cash-pay pharmacy networks, and med-spa chains that also prescribe GLP-1 drugs. It differentiates by keeping the entire stack—consult, compounding, and fulfillment—under one digital roof, avoiding third-party pharmacy delays and offering flat, published pricing with no membership or hidden consult fees.
Doctor-approved weight loss, compounded fresh, shipped to your door in days
Visit site
Goodbodyclinic
Goodbodyclinic is a direct-to-consumer men’s wellness brand that sells FDA-approved generic prescription medications for hair loss, erectile dysfunction, weight management, and skin aging. All products are compounded or repackaged in licensed U.S. pharmacies and shipped in discreet, single-dose pouches; most plans run $79–149 per month, positioning the line in the mid-range tele-health segment. Sales occur exclusively through the brand’s online platform after a free asynchronous physician consultation.
The company’s core promise is “doctor-trusted, pharmacy-delivered” convenience: a 2-minute questionnaire generates a same-day prescription, refills auto-ship every 30 days, and unlimited provider messaging is included. Notable SKUs include topical finasteride/minoxidil spray, sublingual tadalafil, and metformin/GLP-1 weight-loss bundles—each dosed to minimize side effects and bundled with follow-up labs. Packaging is minimalist, travel-friendly, and designed to destigmatize daily medication routines.
Primary customers are 25-45-year-old urban men who want clinical-grade results without in-person doctor visits or big-pharma branding; they value privacy, data transparency, and subscription convenience. Messaging leans on bio-optimization and self-investing rather than “anti-aging,” appealing to fitness-oriented professionals who already track macros and wearables.
Goodbodyclinic competes with tele-medicine pharmacies and subscription men’s health apps that also offer generic Rx bundles. It differentiates by bundling ongoing provider access, lab integration, and condition-specific education into the monthly fee, avoiding the pill-mill perception while staying cheaper and faster than traditional dermatology or urology clinics.
Doctor-approved results delivered to your door, no awkward appointments
Visit site
MyDietDoc
MyDietDoc sells physician-supervised weight-loss programs delivered 100 % online. Core offerings include compounded GLP-1 medications (semaglutide and tirzepatide), metabolic testing kits, and monthly telehealth coaching subscriptions; prices sit in the mid-to-premium tier, typically $250-$450 per month before insurance.
The brand differentiates by pairing every patient with a U.S.-licensed clinician who prescribes and titrates medication without requiring in-person visits, then ships medication from an affiliated compounding pharmacy within 3-5 days. All plans include unlimited messaging, nutrition tracking, and dose adjustments, positioning MyDietDoc as a turnkey medical pathway rather than a supplement or diet plan.
Primary buyers are busy professionals aged 25-55 with 30+ lbs to lose who want clinically proven results but lack time for brick-and-mortar clinics; they value privacy, speed, and medical oversight over flashy lifestyle branding. Messaging emphasizes science, safety, and sustainable weekly fat loss rather than cosmetic quick fixes.
MyDietDoc competes with telehealth GLP-1 startups, cash-pay medical weight-loss chains, and direct-to-consumer supplement brands. It separates itself by bundling prescription authority, personalized titration, and ongoing physician access into one flat monthly fee, avoiding the upsell tiers common among competitors while remaining fully virtual.
Your doctor adjusts your medication while you live your life
Visit site